SEC 13F Intelligence

Capital Research Global Investors / AMGN

Capital Research Global Investors’s Amgen Inc Position

Does Capital Research Global Investors own Amgen Inc (AMGN)? Yes — 6.96M shares worth $2.4B (+0.38% of its 13F portfolio) as of Q1 2026, up from 4.65M shares the prior filed quarter.

Position Value
$2.4B
Q1 2026
Shares
6.96M
% of Portfolio
+0.38%
Quarters Held
30
currently held

Position History AMGN

Reported value by quarter
Q4 ’18: $6.8BQ4 ’18Q1 ’19: $6.3BQ2 ’19: $5.4BQ3 ’19: $6.5BQ4 ’19: $8.5BQ4 ’19Q1 ’20: $6.7BQ2 ’20: $7.9BQ3 ’20: $8.5BQ4 ’20: $7.3BQ4 ’20Q1 ’21: $8.1BQ2 ’21: $7.1BQ3 ’21: $5.7BQ4 ’21: $5.0BQ4 ’21Q1 ’22: $4.5BQ2 ’22: $3.4BQ3 ’22: $2.8BQ4 ’22: $3.1BQ4 ’22Q1 ’23: $2.9BQ2 ’23: $2.1BQ3 ’23: $2.3BQ4 ’23: $1.9BQ4 ’23Q1 ’24: $1.6BQ2 ’24: $1.3BQ3 ’24: $1.3BQ4 ’24: $1.3BQ4 ’24Q1 ’25: $1.4BQ2 ’25: $1.3BQ3 ’25: $1.3BQ4 ’25: $1.5BQ4 ’25Q1 ’26: $2.4Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20266.96M$2.4B+0.38%
Q4 20254.65M$1.5B+0.28%
Q3 20254.73M$1.3B+0.25%
Q2 20254.61M$1.3B+0.26%
Q1 20254.52M$1.4B+0.31%
Q4 20244.89M$1.3B+0.26%
Q3 20244.05M$1.3B+0.27%
Q2 20244.00M$1.3B+0.27%
Q1 20245.67M$1.6B+0.36%
Q4 20236.71M$1.9B+0.48%
Q3 20238.49M$2.3B+0.63%
Q2 20239.57M$2.1B+0.57%
Q1 202311.83M$2.9B+0.82%
Q4 202211.92M$3.1B+0.95%
Q3 202212.61M$2.8B+0.93%
Q2 202214.10M$3.4B+1.07%
Q1 202218.43M$4.5B+1.10%
Q4 202122.16M$5.0B+1.10%
Q3 202126.72M$5.7B+1.33%
Q2 202129.31M$7.1B+1.66%
Q1 202132.62M$8.1B+1.99%
Q4 202031.76M$7.3B+1.90%
Q3 202033.50M$8.5B+2.56%
Q2 202033.36M$7.9B+2.49%
Q1 202033.11M$6.7B+2.63%
Q4 201935.34M$8.5B+2.55%
Q3 201933.59M$6.5B+2.13%
Q2 201929.56M$5.4B+1.73%
Q1 201933.39M$6.3B+2.01%
Q4 201835.14M$6.8B+2.38%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Capital Research Global Investors’s full portfolio or all institutional holders of AMGN.